A Phase 1b Study to Assess the Safety of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2018
At a glance
- Drugs Pexidartinib (Primary) ; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Plexxikon
- 04 Apr 2018 Status changed from active, no longer recruiting to completed.
- 15 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
- 19 Jul 2017 Planned End Date changed from 1 Jun 2018 to 1 Dec 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History